{"categoria": "NULL", "sottotitolo": "UILPA", "testo": "Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company\u2019s \r\n      Board of Directors has declared a cash dividend of $0.63 per share of \r\n      common stock for the second quarter of 2019. The dividend is payable on \r\n      June 27, 2019, to stockholders of record at the close of business on \r\n      June 14, 2019. Future dividends will be subject to Board approval.\r\n    \r\n    \r\n\r\n      \r\nAbout Gilead Sciences\r\n    \r\n\r\n    \r\n\r\n      Gilead Sciences, Inc. is a research-based biopharmaceutical company that \r\n      discovers, develops and commercializes innovative medicines in areas of \r\n      unmet medical need. The company strives to transform and simplify care \r\n      for people with life-threatening illnesses around the world. Gilead has \r\n      operations in more than 35 countries worldwide, with headquarters in \r\n      Foster City, California.\r\n    \r\n    \r\n\r\n      \r\nFor more information on Gilead Sciences, please visit the company\u2019s \r\n      website at www.gilead.com, \r\n      follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs \r\n      at 1-800-GILEAD-5 or 1-650-574-3000.\r\n    \r\n\r\n    \r\n\r\n    \r\n\r\n  \r\n\r\n\r\n\r\n\r\nView source version on businesswire.com: https://www.businesswire.com/news/home/20190502005789/en/\r\n\r\n    \r\n\r\n      \r\nInvestors\r\nRobin Washington(650) \r\n      522-5688\r\n    \r\n    \r\n\r\n      Sung Lee(650) 524-7792\r\n    \r\n  \r\n\r\nPermalink: http://www.businesswire.com/news/home/20190502005789/en", "titolo_articolo": "Gilead Sciences Announces Second Quarter 2019 Dividend", "tags": []}